Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Bausch & Lomb

This article was originally published in The Gray Sheet

Executive Summary

Bausch & Lomb: Firm's board of directors names William Balderston to lead a committee of independent directors that will "review certain of the company's management and control practices in the wake of a recent magazine article." The article, appearing in the Oct. 23 issue of Business Week, raised questions about B&L's internal operating practices. "We have carefully reviewed the company's recent audits and investigations into assertions regarding sales and accounting practices," Balderston said in a company release. "While we have no reason to believe there is a systemic problem, we do take any question about the company's operating methods extremely seriously"...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel